Home >> General Biotechnology >> Diagnostics >> Consumer Goods >>

Global Prenatal and Newborn Genetic Testing Market 2015-2019

Published: Dec-2014 | Format: PDF | Technavio | Number of pages: 70 | Code: MRS - 2911

 

Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can reduce a couple''s uncertainty or help them decide whether to abort a pregnancy in case of conditions such as Down syndrome, trisomy 18, or an open neural tube defect. The procedure includes two blood tests: one in the first trimester and the next in the second trimester. On the other hand, newborn genetic testing is done just after birth to identify genetic disorders.

 

TechNavio''s analysts forecast the Global Prenatal and Newborn Genetic Testing market to grow at a CAGR of 31.91 percent over the period 2014-2019.

 

Covered in this Report

 

This report covers the present scenario and the growth prospects of the Global Prenatal and Newborn Genetic Testing market for the period 2015-2019. The Global Prenatal and Newborn Genetic Testing market can be divided into two segments: Diagnostic Techniques and Screening Methods. To calculate the market size, the report considers revenue generated from these segments.

 

TechNavio''s report, the Global Prenatal and Newborn Genetic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Prenatal and Newborn Genetic Testing market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

 

Key Regions

 

Americas
APAC
EMEA

 

Key Vendors

 

Agilent Technologies
Bio-Rad Laboratories
Illumina
Sequenom

 

Market Driver

 

Growing Incidences of Fetal Health-related Abnormalities
For a full, detailed list, view our report

 

Market Challenge

 

Decrease in Fertility Rates
For a full, detailed list, view our report

 

Market Trend

 

Increase in Number of New Product Launches
For a full, detailed list, view our report

 

Key Questions Answered in this Report

 

What will the market size be in 2019 and what will the growth rate be
What are the key market trends
What is driving this market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the key vendors
What are the strengths and weaknesses of the key vendors

Table of Contents

 

1. Executive Summary
 

2. List of Abbreviations
 

3. Scope of the Report
3.1 Market Overview
3.2 Product Offerings

 

4. Market Research Methodology
4.1 Market Research Process
4.2 Research Methodology

 

5. Introduction
 

6. Market Landscape
6.1 Market Overview
6.2 Market Size and Forecast
6.3 Five Forces Analysis

 

7. Market Segmentation by Technology
 

8. Prenatal Screening Tests
 

9. Causes and Risk Factors

 

10. Genetic Disorders before Birth
 

11. Geographical Segmentation
 

12. Buying Criteria
 

13. Market Growth Drivers
 

14. Drivers and their Impact
 

15. Market Challenges
 

16. Impact of Drivers and Challenges
 

17. Market Trends
 

18. Trends and their Impact
 

19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.3 Other Prominent Vendors

 

20. Key Vendor Analysis
20.1 Agilent Technologies
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation by Revenue 2013
20.1.4 Product Portfolio by Revenue 2013
20.1.5 Business Segmentation by Revenue 2012 and 2013
20.1.6 Geographical Segmentation by Revenue 2013
20.1.7 Business Strategy
20.1.8 Recent Developments
20.1.9 SWOT Analysis
20.2 Bio-Rad Laboratories
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Business Segmentation by Revenue 2013
20.2.4 Product Portfolio by Revenue 2013
20.2.5 Business Segmentation by Revenue 2012 and 2013
20.2.6 Geographical Segmentation by Revenue 2013
20.2.7 Business Strategy
20.2.8 Recent Developments
20.2.9 SWOT Analysis
20.3 Sequenom
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue 2013
20.3.4 Product Portfolio by Revenue 2013
20.3.5 Business Segmentation by Revenue 2012 and 2013
20.3.6 Geographical Segmentation by Revenue 2013
20.3.7 Business Strategy
20.3.8 Recent Developments
20.3.9 SWOT Analysis
20.4 Illumina 
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation by Revenue 2013
20.4.4 Product Portfolio by Revenue 2013
20.4.5 Business Segmentation by Revenue 2012 and 2013
20.4.6 Geographical Segmentation by Revenue 2013
20.4.7 Business Strategy
20.4.8 Recent Developments
20.4.9 SWOT Analysis

 

21. Other Reports in this Series

 

List of Exhibits
 

Exhibit 1: Market Research Methodology
Exhibit 2: Global Prenatal and New-born Genetic Testing Market 2014-2019 (US$ billion)
Exhibit 3: Global Prenatal and New-born Genetic Testing market Segmentation by Technology
Exhibit 5: Global Prenatal and New-born Genetic Testing Market Segmentation by Technology
Exhibit 6: Global Prenatal and New-born Genetic Testing Market Segmentation by Type of Test
Exhibit 7: Global Diagnostic Techniques Market Segmentation by Type of Test
Exhibit 8: Global Screening Methods Market Segmentation by Type of Test
Exhibit 9: Causes and Risk Factors of Prenatal and New-born Genetic Testing
Exhibit 10: Various Genetic Disorders before Birth
Exhibit 11: Global Prenatal and New-born Genetic Testing Market by Geographical Segmentation 2014
Exhibit 12: Global Incidence of Chromosomal Abnormalities in New-borns
Exhibit 13: Declining Fertility Rates
Exhibit 14: Spontaneous Abortions and Fertility Rates as a Function of Maternal Age
Exhibit 15: Risks of Down Syndrome and Chromosomal Abnormalities at Live Birth, According to Maternal Age
Exhibit 16: Agilent Technologies: Business Segmentation by Revenue 2013
Exhibit 17: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 
Exhibit 18: Agilent Technologies: Sales by Geography 2013
Exhibit 19: Bio-Rad Laboratories: Business Segmentation by Revenue 2013
Exhibit 20: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2013 
Exhibit 21: Bio-Rad Laboratories: Sales by Geography 2013
Exhibit 22: Sequenom: Business Segmentation by Revenue 2013
Exhibit 23: Sequenom: Business Segmentation by Revenue 2012 and 2013 
Exhibit 24: Sequenom: Sales by Geography 2013
Exhibit 25: Illumina: Business Segmentation by Revenue 2013
Exhibit 26: Illumina: Business Segmentation by Revenue 2012 and 2013 
Exhibit 27: Illumina: Sales by Geography 2013

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing